Celesio UK has announced that Cormac Tobin has left his position as managing director of the company.
Tobin, who has never shirked from offering his opinion on pharmacy and its prospects in a struggling NHS, leaves the post after more than 10 years with the Celesio group.
“Cormac has been an energetic and trusted leader of our UK and Ireland businesses. He has built a strong leadership team for Celesio UK and his warm and engaging personality made him many friends across community pharmacy and beyond,” said Brian Tyler, chairman of the management board of McKesson Europe which owns Celesio.
“There is a genuine affection for him amongst our colleagues who value his ability to understand customers and patients and put them at the heart of everything we do.
“I am grateful for the dedication that Cormac has shown over the last few years and his leadership through an ever-changing external environment. I wish him every success for the future.”
Tobin’s departure is something of a bolt from the blue. During his time at Celesio, which includes LloydsPharmacy and AAH Pharmaceuticals, he oversaw three major acquisitions and introduced the UK’s first prescription assembly solution that revolutionised off-site dispensing.
“There is a strong and experienced management team in the UK consisting of Nigel Swift, Hilary Stables, Ruth Poole, Catherine McDermott and Marcus Hilger. Together with the entire business in the UK, this leadership team will be able to successfully navigate current and future challenges that the company faces,” Tyler said.
In a statement Celesio said: “Cormac has left with immediate effect and the remaining members of the Celesio UK board will manage the business whilst a successor is sought, reporting to Brian Tyler.”